With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.6372-42-5,Cyclohexyldiphenylphosphine,as a common compound, the synthetic route is as follows.,6372-42-5
n an air atmosphere containing 200mL to gauge stainless steel autoclave was charged with [Rh (acac) (CO)2] (0.07mmol, 18.1mg) and 0.28mmol of a single phosphine ligands L2 and L12, 0.14mmol bidentate phosphite ligand, and 70mL of anhydrous toluene, connecting the gas line to a synthesis gas (hydrogen: carbon monoxide = 1: 1) after the autoclave was replaced three times the gas, the electromagnetic drive a mechanical stirrer, temperature of the autoclave was heated to 100 deg.] C, passed into the synthesis gas to a total pressure of 2.0MPa, at 100 , 2.0MPa reaction conditions 1h, to obtain a rhodium / (bidentate phosphite – single phosphine ligand) complex catalyst HRh (L12) (L2) (CO)
The synthetic route of 6372-42-5 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Shanghai Huayi (Group) Company; Lai, Chunbo; Fan, Manman; Yang, Xushi; Li, Yuan; Gao, Shanlin; Huang, Xiaoyun; Liao, Benren; Chen, Jianwei; Gao, Huimin; Zhang, Chunlei; (21 pag.)CN105566081; (2016); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate